U.S. appeals court upholds Shire?s patents on hyperactivity drug
 

U.S. appeals court upholds Shire?s patents on hyperactivity drug
(Reuters) - A U.S. appeals court has upheld drugmaker Shire's patents for its top-selling drug Vyvanse, blocking five generic drug makers from launching cheaper versions of the drug to treat attention deficit hyperactivity before 2023.
http://i2.wp.com/reuters.us.feedspor...f?resize=1%2C1http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...g8:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...g8:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/VsWApYIw5Q4